Skip to content

Survey Preference therapy the urologist who are affected even by a prostate cancer (PCA)

Survey Preference therapy the urologist who are affected even by a prostate cancer (PCA) - PCA - TEPRAEURO

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00009590
Enrollment
60
Registered
2015-11-04
Start date
2015-11-09
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C61

Interventions

Group 1: - Sending the questionnaire to all patients about the DGU (German Society of Urology) - After a set period of 4 weeks in the cover letter there is a reminder once again via the same distribut

Sponsors

Universitätsklinik für Urologie und Kinderurologie
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
40 Years to No maximum

Inclusion criteria

Inclusion criteria: - Patients =40 years - Disease-specific Men - Urologists with PCA

Exclusion criteria

Exclusion criteria: Non

Design outcomes

Primary

MeasureTime frame
The questionnaire is to examine the treatment preference of urology colleagues, which are themselves affected by prostate cancer. The two-page questionnaire with three-sided attachment is sent to all living urologist in Germany via e-mail distribution of the German Society of Urology (DGU). The data collection and analysis and the publication will be descriptive and anonymized.

Countries

Germany

Contacts

Public ContactMarkus Porsch

Universitätsklinik für Urologie und Kinderurologie

markus.porsch@med.ovgu.de+49-391-67-13354

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026